BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 9278661)

  • 1. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.
    Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E
    Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical surgery and postoperative radiotherapy as combined treatment in rectal cancer. Final results of a phase III study of the European Organization for Research and Treatment of Cancer.
    Arnaud JP; Nordlinger B; Bosset JF; Boes GH; Sahmoud T; Schlag PM; Pene F
    Br J Surg; 1997 Mar; 84(3):352-7. PubMed ID: 9117306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
    James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
    Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
    Thomschke D; Kyau-Ummen B; Halbfass HJ
    Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Michalski W; Bebenek M; Kryj M
    Br J Surg; 2006 Oct; 93(10):1215-23. PubMed ID: 16983741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective surgical adjuvant therapy for high-risk rectal carcinoma.
    Krook JE; Moertel CG; Gunderson LL; Wieand HS; Collins RT; Beart RW; Kubista TP; Poon MA; Meyers WC; Mailliard JA
    N Engl J Med; 1991 Mar; 324(11):709-15. PubMed ID: 1997835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984.
    Greenberg JA; Shibata D; Herndon JE; Steele GD; Mayer R; Bleday R
    Dis Colon Rectum; 2008 Aug; 51(8):1185-91; discussion 1191-4. PubMed ID: 18536973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival.
    Wiltshire KL; Ward IG; Swallow C; Oza AM; Cummings B; Pond GR; Catton P; Kim J; Ringash J; Wong CS; Wong R; Siu LL; Moore M; Brierley J
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):709-16. PubMed ID: 16242252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Swedish Rectal Cancer Trial.
    Eur J Surg; 1996 May; 162(5):397-402. PubMed ID: 8781922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.
    Tulchinsky H; Shmueli E; Figer A; Klausner JM; Rabau M
    Ann Surg Oncol; 2008 Oct; 15(10):2661-7. PubMed ID: 18389322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant therapy of rectal cancer].
    Bouaouina N; Boussen H
    Tunis Med; 2003 Feb; 81(2):73-9. PubMed ID: 12708171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
    Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
    Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term results of preoperative radiation therapy alone for stage T3 and T4 rectal cancer.
    Ahmad NR; Nagle D
    Br J Surg; 1997 Oct; 84(10):1445-8. PubMed ID: 9361610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
    Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
    Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative chemoradiotherapy in rectal cancer. Late results of a pilot study.
    Tersigni R; Alessandroni L; Arcangeli G; Baiano G; Marini P; Micheli A; Sorgi G
    Hepatogastroenterology; 2004; 51(60):1679-85. PubMed ID: 15532804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.